REG - Oakley Capital Inv. - Appointment of Chair Designate and NED

Oakley Capital InvestmentsAnnouncement

Yesterday 07:02

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251029:nRSc1949Fa&default-theme=true

RNS Number : 1949F  Oakley Capital Investments Limited  29 October 2025

29 October 2025

Oakley Capital Investments Limited

Appointment of Chair Designate and Non-Executive Director

Oakley Capital Investments Limited(1) ("OCI") is pleased to announce the
appointment of Christopher Samuel and Kiernan Bell as Independent
Non-Executive Directors, effective 17 November 2025. Christopher Samuel will
become Chair of the Board in March 2026 after a planned transition period and
both appointments are subject to shareholder approval at the Company's 2026
AGM.

Christopher is an experienced Chair and non-executive director with extensive
financial services expertise. Formerly the Chief Executive of Ignis Asset
Management, Christopher also held board-level executive positions at several
asset management businesses including Gartmore, Hill Samuel Asset Management
and Cambridge Place Investment Management. Prior to that he worked at
Prudential-Bache and KPMG, where he qualified as a Chartered Accountant.
Christopher is currently the Chair of Scottish Mortgage Investment Trust plc
and a non-executive director of Quilter plc having previously been Chair of
BlackRock Throgmorton Trust plc, Quilter Financial Planning Limited, JP Morgan
Japanese Investment Trust plc and a non-executive director at Alliance Trust
plc, Sarasin, UIL Limited and UIL Finance Limited.

Kiernan Bell is an experienced legal professional with over 30 years'
experience in corporate governance, restructuring, and commercial litigation.
She has held board positions at several prominent international and financial
services companies, including Atlas Arteria International Limited, Wilton
Reinsurance Bermuda Limited, and HSBC Bermuda Limited. Kiernan is the former
managing partner of the Bermuda office of global law firm Appleby. She also
sits on the panel of Assistant Justices of the Supreme Court of Bermuda and
previously served as an Independent Senator(2) in the Senate of Bermuda.

In addition, Kiernan currently sits as a director on the board of Atlas
Arteria International Limited ("ATLIX"), an exempted mutual fund company
incorporated in Bermuda with global infrastructure investments. The securities
of ATLIX and Atlas Arteria Limited, a public company incorporated in
Australia, are stapled and trade together on the Australian Securities
Exchange (ASX) as Atlas Arteria and are part of the ASX100.

No further information is required to be disclosed, in respect of either Mr
Christopher John Loraine Samuel or Ms Kiernan Jane Bell, pursuant to rule
6.4.8R of the UK Listing Rules.

As at 28 October 2025 Christopher Samuel, and persons closely associated with
him, holds 22,398 shares in OCI.

Steve Pearce, Interim Chair of OCI, commented:

"We welcome Christopher and Kiernan to our Board. Christopher brings deep
industry expertise and a thoughtful, strategic approach to leadership, which
will be a great asset to OCI. The transition period ahead of him becoming
Chair in March will allow for a smooth handover and full engagement with
stakeholders as we plan for OCI's next phase of growth. Kiernan also brings
considerable expertise; her extensive board experience and legal insight will
further enhance the strength and depth of the Board."

Christopher Samuel added:

"I am joining OCI at a time of real momentum for the Company. OCI has a strong
track record of delivering outperformance and is widely recognised as a
leading listed private equity fund. While the recent move to the Main Market
and inclusion in the FTSE 250 reflect a clear strategic ambition to broaden
investor access and enhance market visibility, the Board remains rightly
focused on addressing the long-term discount to NAV at which the shares trade.
I look forward to working with the Board as we explore various strategies to
improve OCI's rating, and drive shareholder returns."

- ends -

 

For further information please contact:

 

Oakley Capital Limited

+44 20 7766 6900

Steven Tredget

 

Greenbrook

+44 20 7952 2000

Rob White / Michael Russell / Theo Bryan

 

Deutsche Numis (Financial Adviser & Broker)

+44 20 7260 1000

Nathan Brown / Matt Goss

 

Notes:

LEI Number: 213800KW6MZUK12CQ815

(1) About OCI

OCI is a closed-ended investment fund trading on the main market of the London
Stock Exchange as an Official List Company. OCI aims to provide shareholders
with consistent long-term capital growth in excess of the FTSE All-Share Index
by providing liquid access to private equity returns through investment in the
Oakley Funds.

A video introduction to OCI is available
at https://oakleycapitalinvestments.com/videos/
(https://oakleycapitalinvestments.com/videos/)

The contents of the OCI website are not incorporated into, and do not form
part of, this announcement.

(2) The Senate of Bermuda

The Senate of Bermuda is the upper house of the bicameral Parliament of
Bermuda. The Senate consists of eleven members, three of whom are independent
senators appointed by the governor.

Oakley Capital, the Investment Adviser

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability
to source attractive growth assets at attractive prices. To do this it relies
on its sector and regional expertise, its ability to tackle transaction
complexity and its deal generating entrepreneur network.

The Oakley Funds

Oakley Capital Private Equity II, Oakley Capital Private Equity III, Oakley
Capital IV, Oakley Capital V, Oakley Capital VI, Oakley Capital Origin and
Oakley Capital Origin II are unlisted lower-mid to mid-market private equity
funds that aim to provide investors with significant long-term capital
appreciation. The investment strategy of the Funds is to focus on buy-out
opportunities in industries with the potential for growth, consolidation and
performance improvement. The Oakley family of funds also includes Oakley
PROfounders Fund III and Oakley Touring Venture Fund, which are venture
capital funds focused on investments in entrepreneur-led, disruptive,
technology led companies.

Important information

The securities of OCI are admitted to the Official List of the Financial
Conduct Authority. Therefore, the Company is required to comply with the
Financial Conduct Authority's Listing Rules, including in relation to
transactions with related parties, financial reporting, contents of
shareholder circulars and other continuing obligations.

This announcement may include "forward-looking statements". These
forward-looking statements are statements regarding OCI's objectives,
intentions, beliefs or current expectations with respect to, amongst other
things, OCI's financial position, business strategy, results of operations,
liquidity, prospects and growth. Forward-looking statements are subject to
risks and uncertainties because they relate to events and depend on
circumstances that may or may not occur in the future. Accordingly, OCI's
actual future financial results, operational performance and achievements may
differ materially from those expressed in, or implied by, the statements.
Given these uncertainties, prospective investors are cautioned not to place
any undue reliance on such forward-looking statements, which speak only as at
the date of this announcement. OCI expressly disclaims any obligation or
undertaking to update or revise any forward-looking statements contained
herein to reflect actual results or any change in OCI's expectations with
regard to them or any change in events, conditions or circumstances on which
any such statements are based unless required to do so by the Financial
Services and Markets Act 2000, the Listing Rules or Prospectus Regulation
Rules of the Financial Conduct Authority or other applicable laws, regulations
or rules.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAFZMZGGRZGKZZ



            Copyright 2019 Regulatory News Service, all rights reserved